• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL RESPICARDIA, INC. REMEDE SYSTEM; IMPLANTED PHRENIC NERVE STIMULATOR FOR CSA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL RESPICARDIA, INC. REMEDE SYSTEM; IMPLANTED PHRENIC NERVE STIMULATOR FOR CSA Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Thrombosis/Thrombus (4440); Swelling/ Edema (4577)
Event Date 12/26/2021
Event Type  Injury  
Event Description
Patient reported swelling and pain in the right arm.Ultrasound confirmed a dvt involving the right internal jugular vein, subclavian vein, axillary vein, and brachial vein treated with anticoagulant.Issue resolved.
 
Manufacturer Narrative
On (b)(6) 2021 the patient underwent a successful remede system implant for central sleep apnea consisting of an implantable pulse generator, a respicardia 4065 stimulation lead, and an abbott 1258t-86 sensing lead.On (b)(6) 2021, the subject reported they had swelling and pain in the right arm treated with tylenol and tramadol with no resolution of pain.On (b)(6) 2021 an ultrasound was reported that demonstrated a dvt involving the right internal jugular vein, subclavian vein, axillary vein, and brachial vein.There was a note of superficial thrombus in the right basilic vein.The patient was started on xarelto 15 mg twice a day for 21 days, followed by 20 mg a day, and norco for pain control.On (b)(6) 2022, the patient was seen in the emergency room for continued pain, while better remained poorly controlled.Pain medication was changed to oxycontin 15 mg twice daily and oxycodone ir for breakthrough pain.It was noted that the swelling in the right neck and right upper extremity had significantly decreased.On (b)(6) 2022 the patient changed to warfarin for cost reasons.In (b)(6) 2022, the subject was evaluated in a medical office and found to be doing great.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REMEDE SYSTEM
Type of Device
IMPLANTED PHRENIC NERVE STIMULATOR FOR CSA
Manufacturer (Section D)
ZOLL RESPICARDIA, INC.
12400 whitewater drive
suite 150
minnetonka MN 55343
Manufacturer (Section G)
ZOLL RESPICARDIA, INC.
12400 whitewater drive
suite 150
minnetonka MN 55343
Manufacturer Contact
kevin bentley
12400 whitewater drive
suite 150
minnetonka, MN 55343
6122865999
MDR Report Key15459110
MDR Text Key300295855
Report Number3009144177-2022-00002
Device Sequence Number1
Product Code PSR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 08/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/18/2022
Initial Date FDA Received09/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
Patient SexFemale
-
-